Jiangsu Bioperfectus Technologies Co Ltd
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, … Read more
Jiangsu Bioperfectus Technologies Co Ltd (688399) - Total Liabilities
Latest total liabilities as of September 2025: CN¥681.04 Million CNY
Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has total liabilities worth CN¥681.04 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangsu Bioperfectus Technologies Co Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jiangsu Bioperfectus Technologies Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guaranty Bancshares, Inc.
NYSE:GNTY
|
USA | $2.81 Billion |
|
American Battery Technology Company Common Stock
NASDAQ:ABAT
|
USA | $4.36 Million |
|
Anbang Save-Guard Group Co.,Ltd.
SHG:603373
|
China | CN¥916.29 Million |
|
Foran Energy Group Co Ltd
SHE:002911
|
China | CN¥15.26 Billion |
|
Techshine Electronics Co. Ltd. A
SHE:301379
|
China | CN¥719.29 Million |
|
Yunnan Salt & Salt Chemical Industry Co Ltd
SHE:002053
|
China | CN¥7.79 Billion |
|
Tian Jin Global Magnetic Card Co Ltd
SHG:600800
|
China | CN¥2.75 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Jiangsu Bioperfectus Technologies Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Bioperfectus Technologies Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)
The table below shows the annual total liabilities of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥489.32 Million | -2.39% |
| 2023-12-31 | CN¥501.31 Million | -54.95% |
| 2022-12-31 | CN¥1.11 Billion | +15.57% |
| 2021-12-31 | CN¥962.89 Million | +57.03% |
| 2020-12-31 | CN¥613.18 Million | +359.06% |
| 2019-12-31 | CN¥133.57 Million | +86.91% |
| 2018-12-31 | CN¥71.46 Million | +41.88% |
| 2017-12-31 | CN¥50.37 Million | +47.74% |
| 2016-12-31 | CN¥34.09 Million | -- |